GSE236502 paclitaxel 1 v 3 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE236502_paclitaxel_1_v_3_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE236502_paclitaxel_1_v_3_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE236502_paclitaxel_1_v_3_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE236502_paclitaxel_1_v_3_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

family with sequence similarity 106 member A

Gene

growth arrest specific 5

Gene

small nucleolar RNA host gene 29

Gene

small nucleolar RNA host gene 5

Gene

differentiation antagonizing non-protein coding RNA

Gene

small nucleolar RNA host gene 3

Gene

ribosomal protein SA 2

Gene

GOLGA2 pseudogene 7

Gene

multidrug resistance-related protein

Gene

small nucleolar RNA host gene 7

  • Gene

    family with sequence similarity 106 member A


  • Gene

    growth arrest specific 5


  • Gene

    small nucleolar RNA host gene 29


  • Gene

    small nucleolar RNA host gene 5


  • Gene

    differentiation antagonizing non-protein coding RNA


  • Gene

    small nucleolar RNA host gene 3


  • Gene

    ribosomal protein SA 2


  • Gene

    GOLGA2 pseudogene 7


  • Gene

    multidrug resistance-related protein


  • Gene

    small nucleolar RNA host gene 7

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.